Business Insight & People News
Medicinal Chemicals & Botanical Products
Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.
Revenue and net income below are for fiscal period FY2026, the period label carried by this company’s own annual XBRL filings to the SEC. Fiscal years do not line up between companies — one company’s FY2026 can cover much the same months as another’s FY2025 — so compare the periods, not just the numbers.
Headcount comes from Yahoo Finance, not from a filing. The date beside it is the day we retrieved the figure — it is not the date the company counted its staff, and Yahoo does not publish that date. Unlike the SEC filings behind the other figures on this page, this one carries no open licence, so we publish the number and nothing else from that source.
Everyone below has filed at least one insider report against this company.
Value is that share count priced at the same closing price used everywhere else on this site. A row priced from only some of a person’s securities says so — we do not quietly present a partial sum as a complete one.
| Insider | Reported role | Shares | Value | Last action |
|---|---|---|---|---|
| Myron W. Wentz | Major Shareholder (10%+) | 7,408,345 | $110.83M | G Bona fide gift Sep 3, 2025 position reported |
The rest — awards, shares withheld to pay tax, option exercises, gifts and so on — follow from an employment contract or a transfer arranged off-market, not from a decision to buy or sell, so counting them would turn this into a pay table.
A price of 0.00 is a real reported figure on gifts (G) and share awards (A) — not a gap in our data.
| Date | Insider | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Sep 3, 2025 | Myron W. Wentz | G Bona fide gift | 145,000 | $0.00 | $0 | SEC filing ↗ |
| May 2, 2025 | Myron W. Wentz | G Bona fide gift | 188,000 | $0.00 | $0 | SEC filing ↗ |
| Nov 13, 2024 | Myron W. Wentz | G Bona fide gift | 123,000 | $0.00 | $0 | SEC filing ↗ |
| Jun 14, 2024 | Myron W. Wentz | S Open-market sale | 13,496 | $45.03 | $607.7K | SEC filing ↗ |
| Jun 12, 2024 | Myron W. Wentz | S Open-market sale | 2,202 | $47.79 | $105.2K | SEC filing ↗ |
| Jun 7, 2024 | Myron W. Wentz | S Open-market sale | 3,700 | $48.61 | $179.9K | SEC filing ↗ |
From SEC Form 4 filings. Every row links to the filing it came from. How we calculate this.
The report an officer, director or large shareholder must file after trading their own company’s stock.
Funds, trusts and other companies file the same ownership forms that executives do. Everything below is taken from those filings, with the position exactly as the filing states it.
Do not add these figures together. 1 of the positions below was reported on a filing shared by several filers at once.
On a joint filing every named filer is listed against the whole position, so the same block of stock appears under each name. Those rows are marked joint.
| Owner | Reported role | Shares | Filed |
|---|---|---|---|
| Gull Global Ltd | TenPercentOwner | 7,408,345 joint |
See the full ownership map — every entity that files as an owner of a US public company.
30 legal entities named in the subsidiary exhibit filed with this company’s most recent 10-K. . Filing on SEC.gov.
This is not the full list. SEC rules only require a company to name its significant subsidiaries.
Smaller entities are left out of the exhibit entirely. A short list here means a short exhibit — it does not mean the company owns nothing else. Nothing on this page is inferred: every name below is copied from the filing.
| Subsidiary | Organised in |
|---|---|
| BabyCare Ltd. | People’s Republic of China |
| Hiya Health Products, LLC | Delaware |
| International Holdings, Inc. | Delaware |
| OOLA Life, Inc. | Utah |
| Pet Lane, Inc. | Delaware |
| PT. USANA Health Sciences Indonesia | Indonesia |
| PT. USANA International Indonesia | Indonesia |
| Rise Wellness, Inc. | Utah |
| Tianjin BabyCare Biological Science and Technology Ltd | People’s Republic of China |
| Tianjin Health Resources Sales Co., Ltd | People’s Republic of China |
| UHS Essential Health (Malaysia) SND BHD | Malaysia |
| UHS Essential Health Philippines, Inc. | Utah |
| USANA Air LLC | Utah |
| USANA Asia Holding Pte. Ltd. | Singapore |
| USANA Australia Pty Ltd | Australia |
| USANA Canada Co. | Canada |
| USANA Canada Holding, Inc. | Delaware |
| USANA Europe GmbH | Germany |
| USANA Health Sciences (Colombia) S.A.S. | Colombia |
| USANA Health Sciences (France) SAS | France |
| USANA Health Sciences (NZ) Corporation | New Zealand |
| USANA Health Sciences (Thailand) Ltd | Thailand |
| USANA Health Sciences China, Inc. | Delaware |
| USANA Health Sciences India Private Limited | India |
| USANA Health Sciences Japan, LLC | Japan |
| USANA Health Sciences Korea, Ltd. | South Korea |
| USANA Health Sciences New Zealand, Inc. | Delaware |
| USANA Health Sciences Singapore Pte. Ltd. | Singapore |
| USANA Hong Kong Limited | Hong Kong |
| USANA Mexico S. de R.L. de C.V. | Mexico |
A subsidiary is a separate legal entity this company controls; it is not the same thing as a brand, a division or an office. These entities do not file with the SEC in their own right, so there is no separate page to open for them.
Think a number here is wrong? Open the linked filing and compare — how to report it.
Every figure on this page comes from filings to the U.S. SEC via EDGAR. Nothing here is estimated, and nothing is taken from press coverage or company websites.
Share count: cover page of the latest filing (dei:EntityCommonStockSharesOutstanding), taken from
USANA HEALTH SCIENCES INC’s own filings and multiplied by our closing price.
Full method.
the share count the company itself prints on the cover of its most recent filing, as of the date it signed that filing.
We do not take a market cap from a data vendor, and we do not estimate one: the figure is a share count from USANA HEALTH SCIENCES INC’s own SEC filings multiplied by the closing price we hold for the same stock.